NEW : Biodentine opens a new door for teeth showing irreversible pulpitis
Today, Biodentine opens a new door for teeth showing irreversible pulpitis
– a condition that until now was dooming the tooth to root canal treatment.
Following the ESE (European Society of Endodontology) position statement for managing the exposed pulp, supported by 3 clinical studies run over the past 3 years showing 95% clinical success, and validated by Septodont’s notified body Biodentine™ can now securely be used even for teeth showing signs and symptoms of irreversible pulpitis, as long as hemostasis can be achieved within 5 minutes. This could represent not less than 85% of the cases.
Click below to access the brochure:
Today, Biodentine opens a new door for teeth showing irreversible pulpitis – a condition that until now was dooming the tooth to root canal treatment.
Following the ESE (European Society of Endodontology) position statement for managing the exposed pulp, supported by 3 clinical studies run over the past 3 years showing 95% clinical success, and validated by Septodont’s notified body Biodentine™ can now securely be used even for teeth showing signs and symptoms of irreversible pulpitis, as long as hemostasis can be achieved within 5 minutes. This could represent not less than 85% of the cases.
Click below to access the brochure:
Today, Biodentine opens a new door for teeth showing irreversible pulpitis – a condition that until now was dooming the tooth to root canal treatment.
Following the ESE (European Society of Endodontology) position statement for managing the exposed pulp, supported by 3 clinical studies run over the past 3 years showing 95% clinical success, and validated by Septodont’s notified body Biodentine™ can now securely be used even for teeth showing signs and symptoms of irreversible pulpitis, as long as hemostasis can be achieved within 5 minutes. This could represent not less than 85% of the cases.
Click below to access the brochure:
